Skip to main content
. 2022 Aug 1;11(1):1910–1919. doi: 10.1080/22221751.2022.2088406

Figure 2.

Figure 2.

Efficacy of heterologous boost with V-01 vaccine preventing COVID-19 in subgroup according to mITT analysis. Vaccine efficacy was defined as the percentage reduction in the hazard ratio of V-01 vaccine group to the placebo group for the confirmed COVID-19. A stratified Cox proportional hazards model adjusting for covariates was applied to estimate the efficacy as well as its confidence interval.